ArticleJournal of clinical medicine2021

Combined Inhibition of TGF-β1-Induced EMT and PD-L1 Silencing Re-Sensitizes Hepatocellular Carcinoma to Sorafenib Treatment.

Ritu Shrestha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.